產品編號 | bs-41107P |
英文名稱 | Human Purified Myoglobin |
中文名稱 | 肌紅蛋白 |
別 名 | MB; MGC13548; PVALB; MYG_HUMAN; Human Purified Myoglobin |
Specific References (1) | bs-41107P has been referenced in 1 publications.
[IF=8.008] Shiyu Zang. et al. Hyperbranched Tetraphenylethylene Derivatives with Low Non-specific Aggregation-Induced Emission for Fluorescence Recognition of Proteins with Hydrophobic Pockets. ANAL CHEM. 2022;94(23):8365–8372
|
|
理論分子量 | 17kDa |
性 狀 | Liquid |
濃 度 | >1.0 mg/ml |
物 種 | Human |
序 列 | Purified native protein |
純 度 | >95% as determined by SDS-PAGE |
內毒素 | Not analyzed |
活性 | Yes |
緩 沖 液 | 50 mM Tris-HCl (pH=7.4) with 0.05% NaN3. |
保存條件 | Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles. |
注意事項 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
產品介紹 |
Myoglobin is a small heme containing protein responsible for the oxygen deposition in muscle tissues. Only one form of myoglobin is expressed in cardiac and skeletal muscles. Myoglobin is known as a marker of myocardial damage and it has been used for more than three decades. Nowadays it still is very commonly used in clinical practice as an early marker of AMI. It appears in patient's blood 1 to 3 hours after onset of the symptoms, reaching peak level within 8 to 12 hours. Myoglobin is not so cardiac specific as cTnI or cTnT. Because of high myoglobin concentration in skeletal muscle tissue, even minor skeletal muscle injury results in the significant increase of myoglobin concentration in blood. Thus myoglobin is used together with cTnI or cTnT in clinical practise for better specificity in AMI diagnosis. SWISS: P02144 Gene ID: 4151 |
1、抗體溶解方法 | |
2、抗體修復方式 | |
3、常用試劑的配制 | |
4、免疫組化操作步驟 | |
5、免疫組化問題解答 | |
6、Western Blotting 操作步驟 | |
7、Western Blotting 問題解答 | |
8、關于肽鏈的設計 | |
9、多肽的溶解與保存 | |
10、酶標抗體效價測定程序 | |